Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease

PDE type 5 inhibitors (PDE5Is), such as sildenafil, tadalafil and vardenafil, are a class of drugs used to prolong the physiological effects of NO/cGMP signalling in tissues through the inhibition of cGMP degradation. Although these agents were originally developed for the treatment of hypertension...

Celý popis

Podrobná bibliografie

Vydáno v:	British journal of pharmacology Ročník 177; číslo 24; s. 5467 - 5488
Hlavní autoři:	Tzoumas, Nikolaos, Farrah, Tariq E., Dhaun, Neeraj, Webb, David J.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Blackwell Publishing Ltd 01.12.2020 John Wiley and Sons Inc
Témata:	Angina Cardiovascular diseases Cerebral infarction Cyclic GMP Diabetes mellitus Erectile dysfunction Hypertension Kidney diseases Myocardial infarction Review Sildenafil TARGETING THE NITRIC OXIDE (NO)‐cGMP PATHWAY: THERAPEUTIC OPPORTUNITIES IN THE 21ST CENTURY
ISSN:	0007-1188, 1476-5381, 1476-5381
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!